SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-587089
Filing Date
2016-05-11
Accepted
2016-05-11 16:03:04
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d180210d10q.htm 10-Q 302233
2 EX-31.1 d180210dex311.htm EX-31.1 8209
3 EX-31.2 d180210dex312.htm EX-31.2 8199
4 EX-32.1 d180210dex321.htm EX-32.1 4244
  Complete submission text file 0001193125-16-587089.txt   2682527

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cbay-20160331.xml EX-101.INS 514546
6 XBRL TAXONOMY EXTENSION SCHEMA cbay-20160331.xsd EX-101.SCH 36629
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20160331_cal.xml EX-101.CAL 51625
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20160331_def.xml EX-101.DEF 92199
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20160331_lab.xml EX-101.LAB 286795
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20160331_pre.xml EX-101.PRE 190749
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 161639895
SIC: 2834 Pharmaceutical Preparations